Form D Explorer

Source evidence

Aegle Therapeutics Corp · 0001797825-26-000007

D filed Aug. 28, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
WOBURN
street1
400 TRADECENTER
street2
SUITE 5900
zipCode
01801
entityName
Aegle Therapeutics Corp
entityType
Corporation
stateOrCountry
Massachusetts
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold2277698number2277698/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount2277698number2277698/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count17number17/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: d4ecf311f53bbd71a4dd79d7eea4bd88b4e5ff7edda61f6a65bea6c6a3f7549d. This proves extraction identity, not the accuracy of the filer's claims.